Immunology of Infectious Disease News 8.07 February 26, 2020 | |
| |
TOP STORYAn Immune-Cell Signature of Bacterial Sepsis Researchers used single-cell RNA-sequencing to profile the blood of people with sepsis across three clinical cohorts with corresponding controls. They profiled total peripheral blood mononuclear cells and dendritic cells across all subjects and, on the basis of clustering of their gene-expression profiles, defined 16 immune-cell states. [Nat Med] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Xenosiderophore Utilization Promotes Bacteroides thetaiotaomicron Resilience During Colitis Scientists identified B. thetaiotaomicron genes that were upregulated during Salmonella-induced gut inflammation and were predicted to be involved in iron uptake. Mutants in the xusABC locus were defective for xenosiderophore-mediated iron uptake in vitro. [Cell Host Microbe] Abstract | Graphical Abstract Researchers report that interferons (IFNs)-I promoted the dysregulation of iron homeostasis in macrophages during systemic infections with the intracellular pathogen Candida glabrata, leading to fungal survival and persistence. By engaging JAK1, IFNs-I disturbed the balance of the transcriptional activator NRF2 and repressor BACH1 to induce downregulation of the key iron exporter Fpn1 in macrophages. [Cell Host Microbe] Abstract | Graphical Abstract A Quantitative Genetic Interaction Map of HIV Infection A viral host-dependency epistasis map provided an expansive view of the genetic dependencies underlying HIV infection and could be used to identify drug targets and study viral mutations. Scientists found that the RNA deadenylase complex, CNOT, was a central player in the vE-MAP and showed that knockout of CNOT1, 10, and 11 suppressed HIV infection in primary T cells by upregulating innate immunity pathways. [Mol Cell] Abstract | Graphical Abstract Investigators showed that a human monoclonal antibody with pan-amyloid-binding activity could disrupt biofilms formed by Salmonella enterica serovar Typhimurium in vitro and in vivo. The antibody disrupted the biofilm structure, enhancing biofilm eradication by antibiotics and immune cells. [Nat Commun] Full Article The authors demonstrated that chronic lymphocytic choriomeningitis virus infection rapidly triggered severe thymic depletion, mediated by CD8 T cell-intrinsic type I interferon and signal transducer and activator of transcription 2 signaling. [Proc Natl Acad Sci USA] Abstract Researchers investigated the effect of a genetic polymorphism at position -21 of HLA-B on the phenotype and functional capacity of peripheral blood NK cells in a cohort of 36 African individuals with HIV type 1/human cytomegalovirus co-infection. [Front Immunol] Full Article Scientists investigated an epizootic of the highly pathogenic A(H7N7) in the Netherlands, which in 2003 led to infection of 89 peoples and one fatal case. Subtype-specificity of antibodies were determined for confirmed H7N7 infected individuals, contacts of these cases and a comparison group controls, by microarray, using recombinant hemagglutinin 1 proteins. [Sci Rep] Full Article Leucine-Rich Alpha 2 Glycoprotein Is a New Marker for Active Disease of Tuberculosis Researchers investigated whether leucine-rich alpha-2 glycoprotein (LRG), a new inflammatory biomarker, could be used to assess active disease of tuberculosis (TB). Cynomolgus macaques pretreated with or without Bacille Calmette-Guerin vaccination were inoculated with Mycobacterium TB to induce active TB. Blood was collected over time from these animals and levels of LRG as well as CRP and ESR were quantified. [Sci Rep] Full Article Human Antibody Repertoire following Ebola Virus Infection and Vaccination Higher antibody binding and affinity to GP was observed in survivors compared with vaccinated plasma that correlated with Ebola virus neutralization. Surprisingly, a predominant IgM response was generated after prime-boost vaccination whereas survivors demonstrated IgG dominant antibody response. [iScience] Abstract | Graphical Abstract Granzyme B Attenuates Bacterial Virulence by Targeting Secreted Factors Investigators showed that granzyme B degraded multiple secreted virulence mediators from Listeria monocytogenes, Salmonella typhimurium and Mycobacteria tuberculosis. Pathogenic bacteria, when infected in presence of granzyme B or granzyme-secreting killer cells, failed to grow in human macrophages and epithelial cells due to their crippled virulence. [iScience] Abstract | Graphical Abstract Subscribe to our sister publications: Human Immunology News & Immune Regulation News. | |
| |
REVIEWSChytrid Fungi and Global Amphibian Declines Scientists describe how the use of multidisciplinary biological approaches has been essential to pinpointing the origins of amphibian-parasitizing chytrid fungi, including Batrachochytrium dendrobatidis and Batrachochytrium salamandrivorans, as well as to timing their emergence, tracking their cycles of expansion and identifying the core mechanisms that underpin their pathogenicity. [Nat Rev Microbiol] Abstract The authors discuss recent advancements in understanding the interplay between immune cells and the microbiota and how they may relate to recovery from Clostridioides difficile through fecal microbiota transplantation therapy. [Trends Mol Med] Full Article Trypanosoma Cruzi Calreticulin: Immune Evasion, Infectivity, and Tumorigenesis Trypanosoma cruzi calreticulin (TcCalr) is a multifunctional, endoplasmic reticulum-resident chaperone that, translocated to the external microenvironment, mediates crucial host-parasite interactions. TcCalr binds and inactivates C1 and mannose-binding lectin/ficolins, important pattern- recognition receptors of the complement system. [Trends Parasitol] Abstract Visit our reviews page to see a complete list of reviews in the immunology of infectious disease research field. | |
| |
INDUSTRY NEWSThe Institute of Human Virology at the University of Maryland School of Medicine and OncoImmune, Inc. launched a new Phase II clinical trial called CALIBER, which will test whether OncoImmune’s lead product, CD24Fc, can reduce late effects of HIV infection, such as inflammatory abnormalities including cardiovascular disease. [University of Maryland School of Medicine (BusinessWire, Inc.)] Press Release Harvard, Guangzhou Institute Launch $115M Coronavirus Research Collaboration Researchers at Harvard University and the Guangzhou Institute of Respiratory Health in China will partner to develop therapies designed to prevent new infections and treat existing ones, through a $115 million research collaboration funded by Chinese real estate giant China Evergrande Group. [Harvard University (Genetic Engineering & Biotechnology News)] Press Release Clover Biopharmaceuticals announced that it has entered into a research collaboration with GSK for its protein-based coronavirus vaccine candidate. GSK will provide Clover with its pandemic adjuvant system for further evaluation of S-Trimer in pre-clinical studies. [Clover Biopharmaceuticals] Press Release Pediatric Researchers in Montreal Unite to Tackle Infection and Immunity on Two Different Fronts Researchers at the Montreal Children’s Hospital of the McGill University Health Center and the CHU Sainte-Justine are coming together within the scope of two new projects, funded under the auspices of the McGill Interdisciplinary Initiative in Infection and Immunity: improving the diagnosis and treatment of bacterial pneumonia and better understanding rare immune disorders. [McGill University] Press Release Moderna Ships mRNA Vaccine against Novel Coronavirus (mRNA-1273) for Phase I Study Moderna, Inc. announced that it has released the first batch of mRNA-1273, the company’s vaccine against the novel coronavirus, for human use. Vials of mRNA-1273 have been shipped to the National Institute of Allergy and Infectious Diseases, a part of the National Institutes of Health to be used in the planned Phase I study in the US. [Moderna, Inc.] Press Release Five Prime Therapeutics, Inc. announced a global license agreement with Seattle Genetics, Inc. to develop and commercialize novel ADC therapies using monoclonal antibodies developed by Five Prime. [Five Prime Therapeutics, Inc.] Press Release | |
| |
POLICY NEWSTime to Use the P-Word? Coronavirus Enters Dangerous New Phase The spread of the new coronavirus could soon become unstoppable, say scientists who are concerned about a rapid surge in the number and size of outbreaks outside China. Some are even muttering the p-word: pandemic. [Nature News] Editorial Coronavirus Latest: Brazil Reports First Case in South America A case of COVID-19 has been confirmed in Brazil — the first in South America. On 26 February, Brazil’s minister of health, Luiz Henrique Mandetta, confirmed that a man who traveled to northern Italy between 9 and 21 February has the disease. [Nature News] Editorial
| |
EVENTSNEW World Vaccine Congress Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESScientist – Immunology (STEMCELL Technologies Inc.) Department Chair – Microbiology and Immunology (Western University) Postdoctoral Researcher – Pathogen/Host Cell Interactions (University Hospital of Müenster) Postdoctoral Researcher – Microtubules in Viral Infection (Northwestern Feinberg School of Medicine) Postdoctoral Fellow – HIV (Massachusetts General Hospital) Postdoctoral Fellow – Vaccine Research (University of Rhode Island) Postdoctoral Scientist – Tuberculosis Research (Texas Biomedical Research Institute) Research Associate – Immunology (University Hospital of Muenster) Postdoctoral Fellow – Immunology (Harvard T.H. Chan School of Public Health) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immunology of Infectious Disease News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|